Emyria Expands National Reach with New Brisbane Clinic

Emyria Ltd ( (AU:EMD) ) has provided an update.

Emyria has signed a landmark agreement with Avive Health to establish an Empax clinic in Brisbane, marking its first location in Queensland. This expansion is part of Emyria’s national rollout strategy to deliver specialized, reimbursable care for treatment-resistant mental health conditions, leveraging partnerships to scale efficiently and address increasing patient demand. The agreement provides Emyria with exclusive rights to deliver its PTSD and treatment-resistant depression programs at the Brisbane site, with potential expansion into Victoria and South Australia. This move follows a significant agreement with Medibank Private Ltd, enhancing Emyria’s position in the mental health industry and expanding patient access to innovative care.

More about Emyria Ltd

Emyria Limited is a leader in developing and delivering innovative mental health treatments, focusing on specialized care for treatment-resistant mental health conditions. The company is expanding its national footprint by establishing clinics in partnership with private hospitals, aiming to address Australia’s growing mental health crisis.

Average Trading Volume: 2,294,736

Technical Sentiment Signal: Hold

Current Market Cap: A$25.07M

For detailed information about EMD stock, go to TipRanks’ Stock Analysis page.